Since Donald Trump took office in 2016, the FDA has drastically decreased the number of formal warning letters and other regulatory actions it undertakes
Compliance and enforcement actions by the US Food and Drug Administration (FDA) have dramatically declined under the Trump administration, with medical devices seeing the steepest drop, according to a new report.











